Preclinical and clinical pharmacology of antisense oligonucleotides

Author： Marcusson E. Yacyshyn B. Shanahan W. Dean N.

ISSN： 1073-6085

Source： Molecular Biotechnology, Vol.12, Iss.1, 1999-08, pp. : 1-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense oligonucleotides: towards clinical trials

By Agrawal S.

Trends in Biotechnology, Vol. 14, Iss. 10, 1996-10 ,pp. : 376-387

Elsevier

Access to resources Recommend Favorite

Antisense therapy in clinical oncology: Preclinical and clinical experiences

By Tamm Ingo Wagner Mandy

Molecular Biotechnology, Vol. 33, Iss. 3, 2006-07 ,pp. : 221-238

Humana Press, Inc

Access to resources Recommend Favorite

Fluorescent labelling of oligonucleotides using terminal transferase

By McEwan N.R.

Biotechnology Techniques, Vol. 11, Iss. 10, 1997-01 ,pp. : 727-728

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Different Conditions for Ligating Dumbbell-Shaped Oligonucleotides

By Yamagiwa Hiroshi Bolander Mark E. Sarkar Gobinda

Molecular Biotechnology, Vol. 26, Iss. 2, 2004-02 ,pp. : 111-116

Humana Press, Inc

Access to resources Recommend Favorite

Modulation of human interferon-γ biosynthesis by antisense oligodeoxynucleotides

By Boeve Christine Ley Marc

Molecular Biotechnology, Vol. 14, Iss. 2, 2000-02 ,pp. : 157-163

Humana Press, Inc

Access to resources Recommend Favorite